REGN6569
REGN6569 is a fully human IgG1 monoclonal antibody targeting glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) with high specificity for GITR. REGN6569 exerts stronger in vitro antibody-dependent cell-mediated cytotoxicity (ADCC) against regulatory T cells expressing GITR. REGN6569 selectively depletes regulatory T cells via antibody-dependent cell-mediated cytotoxicity and increases the proportion of proliferative natural killer (NK) cells in peripheral blood. REGN6569 is applicable for advanced solid malignancies. Isotype control: HY-P99001.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Isotype
Human IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
GITR |
In Vitro
REGN6569, a fully human immunoglobulin G1 monoclonal antibody specific for GITR, exhibits in vitro ADCC activity with preferential cytotoxicity toward GITR-expressing Tregs relative to CD8+ T cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Target
TNFRSF18/GITR/CD357
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Application
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- REGN6569
- REGN 6569
- REGN-6569
- TNF Receptor
- Tumor Necrosis Factor Receptor
- TNFR
- GITR
- mucoepidermoid tumor of the parotid gland
- colorectal cancer
- regulatory T cells
- anti-programmed cell death-1 therapy
- advanced head and neck squamous cell carcinoma
- advanced solid tumors
- natural killer cells
- B3 thymoma
- CD8+ T cells
- Inhibitor
- inhibitor
- inhibit